JP2023156197A - ＳＡＲＳ－ＣｏＶ－２結合ペプチド - Google Patents

ＳＡＲＳ－ＣｏＶ－２結合ペプチド Download PDF

Info

Publication number
JP2023156197A
JP2023156197A JP2022065934A JP2022065934A JP2023156197A JP 2023156197 A JP2023156197 A JP 2023156197A JP 2022065934 A JP2022065934 A JP 2022065934A JP 2022065934 A JP2022065934 A JP 2022065934A JP 2023156197 A JP2023156197 A JP 2023156197A
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
substituted
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022065934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023156197A5 (https=
Inventor
佑太 松村
Yuta Matsumura
峻亮 稲浦
Shunsuke Inaura
大貴 西口
Hiroki Nishiguchi
重文 熊地
Shigefumi Kumachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Epsilon Molecular Engineering Inc
Original Assignee
Kao Corp
Epsilon Molecular Engineering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp, Epsilon Molecular Engineering Inc filed Critical Kao Corp
Priority to JP2022065934A priority Critical patent/JP2023156197A/ja
Publication of JP2023156197A publication Critical patent/JP2023156197A/ja
Publication of JP2023156197A5 publication Critical patent/JP2023156197A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2022065934A 2022-04-12 2022-04-12 ＳＡＲＳ－ＣｏＶ－２結合ペプチド Pending JP2023156197A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022065934A JP2023156197A (ja) 2022-04-12 2022-04-12 ＳＡＲＳ－ＣｏＶ－２結合ペプチド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022065934A JP2023156197A (ja) 2022-04-12 2022-04-12 ＳＡＲＳ－ＣｏＶ－２結合ペプチド

Publications (2)

Publication Number Publication Date
JP2023156197A true JP2023156197A (ja) 2023-10-24
JP2023156197A5 JP2023156197A5 (https=) 2025-04-02

Family

ID=88421226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022065934A Pending JP2023156197A (ja) 2022-04-12 2022-04-12 ＳＡＲＳ－ＣｏＶ－２結合ペプチド

Country Status (1)

Country Link
JP (1) JP2023156197A (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022008067A (ja) * 2020-05-01 2022-01-13 花王株式会社 抗ＳＡＲＳ－ＣｏＶ－２抗体

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022008067A (ja) * 2020-05-01 2022-01-13 花王株式会社 抗ＳＡＲＳ－ＣｏＶ－２抗体

Similar Documents

Publication Publication Date Title
CN112010965B (zh) 一种针对新冠病毒SARS-CoV-2棘突蛋白RBD区的单克隆抗体及其应用
JP6215223B2 (ja) マルチプレックス免疫スクリーニングアッセイ
KR102671155B1 (ko) Ns1 단백질의 결합 단백질
KR102785081B1 (ko) 항 인간 심근 트로포닌 i의 항체 및 그 사용
KR102792597B1 (ko) Ns1-결합 단백질
KR102785063B1 (ko) Ns1 단백질의 결합 단백질 및 응용
US20240117012A1 (en) Anti-sars-cov-2 antibody
KR102785236B1 (ko) 항 인간 심근 트로포닌 i의 항체 및 그 사용
JP7414225B2 (ja) ＳＡＲＳ－ＣｏＶ－２結合ペプチド
JP7038367B2 (ja) 抗ＳＡＲＳ－ＣｏＶ－２抗体
JP2023156197A (ja) ＳＡＲＳ－ＣｏＶ－２結合ペプチド
JP2024151260A (ja) 抗ＳＡＲＳ－ＣｏＶ－２抗体
WO2023199955A1 (ja) 抗ＳＡＲＳ－ＣｏＶ－２抗体
CN105542003B (zh) 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体
JP7174961B2 (ja) 抗ＳＡＲＳ－ＣｏＶ－２抗体を用いた医薬品及び検査キット
CN121537507B (zh) 一种抗mers的纳米抗体、纳米抗体融合蛋白及其应用
TW202204381A (zh) 重組抗體、包含重組抗體之套組及其用途
CA3109433C (en) Ns1-binding protein and uses thereof
JP2024165150A (ja) ＳＡＲＳ－ＣｏＶ－２中和抗体
CN116547004A (zh) SARS-CoV-2结合肽
KR20250095812A (ko) 항-sfts 바이러스 항체 및 이의 용도
KR20250090408A (ko) 인간 코로나바이러스에 중화활성을 갖는 엔지니어링된 인간 항체

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260106